Impending Net Drug Price Transparency Regulatio...

By Rene Pretorius

June 27, 2025

A new CMS rule to force drug price transparency is poised to reshape the pharmaceutical and healthcare landscape. With regulat...
How Does Mind’s AI-Driven Mental Healthcare Transform Care?
DALY Modeling Methods for Enhanced Health Economics and Policy Analysis
Pharmaceutical Pricing Issues: Beyond Overpricing and Profit Motives
FDA Approval and Access Strategy for Lenacapavir (Yeztugo) Long-Acting HIV Pr...
Canada Launches Consultation for Essential Prescription Drugs List
NICE Rejects Donanemab: Treatment Cost-Effectiveness
PCV20 Reimbursement Guidelines: Analysis of Dutch Advisory Council Recommenda...
NICE Approves Transformative Multiple Myeloma Treatment
EHK Clusters 2026 Report: Enhancements in Dutch Risk Equalization for High-Co...
Future-Proofing Hospitals: Singapore’s Blueprint for Smarter Healthcare
Pfizer Conference Insights: Analyzing Bourla’s Strategic Vision Amid Po...
What are the Plans and Implications for Keytruda´s Biosimilar